We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+25.43%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.81B
AUM Growth
-$137M
Cap. Flow
-$1.22B
Cap. Flow %
-31.92%
Top 10 Hldgs %
21.26%
Holding
2,518
New
496
Increased
380
Reduced
669
Closed
943

Top Sells

Rank Stock Value
1
XYZ
Block Inc
XYZ
+$36.2M
2
IMMU
Immunomedics Inc
IMMU
+$30.5M
3
ORCL icon
Oracle
ORCL
+$26.2M
4
LLY icon
Eli Lilly
LLY
+$26.2M
5
CVNA icon
Carvana
CVNA
+$25.6M

Sector Composition

Rank Sector Weight
1 Technology 8.86%
2 Consumer Discretionary 6.41%
3 Financials 4.85%
4 Industrials 4.41%
5 Healthcare 4.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AG icon
1576
First Majestic Silver
AG
$7.41B
-75,900
Closed -$721K
AGG icon
1577
iShares Core US Aggregate Bond ETF
AGG
$137B
-94
Closed -$11K
AGIO icon
1578
Agios Pharmaceuticals
AGIO
$1.79B
-41,200
Closed -$1.44M
AGNC icon
1579
AGNC Investment
AGNC
$12.4B
-14,449
Closed -$201K
AGO icon
1580
Assured Guaranty
AGO
$3.66B
-29,903
Closed -$641K
AIT icon
1581
Applied Industrial Technologies
AIT
$12.8B
-15,936
Closed -$878K
AJG icon
1582
Arthur J. Gallagher & Co
AJG
$64.1B
-11,502
Closed -$1.21M
AKR icon
1583
Acadia Realty Trust
AKR
$3.09B
-31,656
Closed -$333K
ALEC icon
1584
Alector
ALEC
$168M
-10,464
Closed -$110K
ALEX
1585
DELISTED
Alexander & Baldwin
ALEX
-14,691
Closed -$165K
ALNY icon
1586
CALL
Alnylam Pharmaceuticals
ALNY
$27.5B
-5,200
Closed -$757K
ALNY icon
1587
Alnylam Pharmaceuticals
ALNY
$27.5B
-43,141
Closed -$6.28M
ALSN icon
1588
Allison Transmission
ALSN
$9.5B
-42,318
Closed -$1.49M
ALV icon
1589
Autoliv
ALV
$9.02B
-3,613
Closed -$263K
AM icon
1590
Antero Midstream
AM
$10.4B
-603,771
Closed -$3.24M
AMCX icon
1591
AMC Global Media
AMCX
$492M
-60,232
Closed -$1.49M
AMED
1592
DELISTED
Amedisys
AMED
-7,735
Closed -$1.83M
AMN icon
1593
AMN Healthcare
AMN
$1.3B
-3,604
Closed -$211K
AMRX icon
1594
Amneal Pharmaceuticals
AMRX
$5.85B
-42,039
Closed -$163K
AMSF icon
1595
AMERISAFE
AMSF
$543M
-10,209
Closed -$586K
AMWD
1596
DELISTED
American Woodmark
AMWD
-4,531
Closed -$356K
AN icon
1597
AutoNation
AN
$7.11B
-11,718
Closed -$621K
ANDE icon
1598
Andersons Inc
ANDE
$2.41B
-15,946
Closed -$306K
ANSS
1599
DELISTED
Ansys
ANSS
-4,257
Closed -$1.39M
ANVS icon
1600
Annovis Bio
ANVS
$74.4M
-17,164
Closed -$83K

Similar funds

Paloma Partners's Q4 2020 Portfolio in Review

As of Q4 2020, Paloma Partners held 2,518 positions worth $3.81B, down 3.5% from $3.95B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Paloma Partners withdrew a net $1.22B in Q4 2020, closing 943 positions and reducing 669 holdings. Its most notable exit was Immunomedics Inc, an estimated $30.5M position sold in full.

By sector, the portfolio is most concentrated in Technology at 8.9% of assets, down from 9.3% a quarter earlier, followed by Consumer Discretionary and Financials.

Against the trend, Paloma Partners opened a new position in Danaher worth $13.7M.

  • Paloma Partners's largest Q4 2020 buy was Danaher: 69,494 shares worth $13.7M.
  • Paloma Partners added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $56.5M increase.
  • Paloma Partners's biggest Q4 2020 reduction was Block Inc, cutting an estimated $36.2M.
  • Paloma Partners fully exited Immunomedics Inc in Q4 2020, selling an estimated $30.5M.
  • Paloma Partners's ten largest holdings make up 21% of its $3.81B portfolio in Q4 2020.
  • Paloma Partners opened 496 new positions and closed 943 in Q4 2020.
  • Paloma Partners's portfolio value fell 3.5% quarter-over-quarter to $3.81B.

Based on Paloma Partners's 13F filing for Q4 2020, filed 16 Feb 2021.